Health Care ANGO Earnings: A snapshot of AngioDynamics’ Q2 2024 results 2 years ago AngioDynamics Inc. (NASDAQ: ANGO) on Wednesday reported a net loss, on an adjusted basis, for the second quarter of 2024… Walgreens Boots Alliance (WBA) Q1 2024 profit and sales beat estimates 2 years ago Walgreens Boots Alliance, Inc. (NASDAQ: WBA) on Thursday reported stronger-than-expected earnings and revenues for the first quarter of 2024. Net… Walgreens (WBA) to report Q1 results on Thursday. Here’s what to expect 2 years ago Walgreens Boots Alliance, Inc. (NASDAQ: WBA) is scheduled to report first-quarter earnings on Thursday, amid expectations for a mixed outcome.… Earnings Summary: Highlights of CooperCompanies’ (COO) Q4 2023 financial results 2 years ago Medical device maker CooperCompanies (NYSE: COO) announced financial results for the fourth quarter of 2023, reporting an increase in revenues… Ocean Biomedical’s breast cancer research uncovers new tumor suppression pathway for its proprietary antibody 2 years ago Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said that new findings, co-authored by the company’s scientific co-founder Jack… Johnson & Johnson (JNJ) focuses on innovation after separating consumer business 2 years ago Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) recently raised its full-year guidance to reflect the strong performance of the pharmaceutical… Agilent Technologies (A) Earnings: 4Q23 Key Numbers 2 years ago Agilent Technologies Inc. (NYSE: A) reported revenue of $1.69 billion for the fourth quarter of 2023, down 8.7% on a… Medtronic (MDT) Q2 2024 adj. earnings decline despite revenue growth 2 years ago Medical device maker Medtronic plc (NYSE: MDT) reported a decline in adjusted earnings for the second quarter of 2024, despite… Earnings Summary: Highlights of Catalent’s Q1 2024 results 2 years ago Catalent, Inc. (NYSE: CTLT), a provider of delivery technologies and development solutions to the pharmaceutical industry, has reported earnings for… Ocean Biomedical, Inc. (NASDAQ: OCEA) Research Summary 2 years ago Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biotechnology company focused on transforming biomedical inventions into cutting-edge therapies. The company develops… Next» « Previous